Addressing the Disc Brake Standard The adoption of disc brakes in road cycling introduced new mechanical challenges, primarily concerning how wheels manage asymmetrical forces. Unlike rim brakes, ...
Over the past few decades, electronics engineers have been trying to develop new neuromorphic hardware, systems that mirror the organization of neurons in the human brain. These systems could run ...
Data from PdM programs across mining and aggregates facilities reveals a clear pattern. The following five fault types are the most commonly detected and offer the greatest opportunity to intervene ...
Hailing from Houston, Texas, Warren was a consensus four-star prospect after starring at Fort Bend Christian Academy. He was the 140th-ranked player in the class of 2024, according to the 247Sports ...
The Houston Cougars and head coach Willie Fritz were tasked to build on the momentum the program was able to create in the 2025 season, as the Cougars ended the year with a 10-3 record and with their ...
Oregon football addressed its depth along the defensive line with another transfer portal addition Wednesday. Howard transfer Derrick Brown Jr. announced his commitment to the Ducks. Heading into his ...
Regenxbio Inc (RGNX) showcases robust pipeline progress and financial stability, despite regulatory challenges.
Of the newcomers in Auburn’s rebuilt offense, much of the attention has gone to former USF quarterback Byrum Brown. Given Brown’s production with the Bulls, that makes sense. But one of his USF ...
By not dipping into the portal for a QB, Alabama made it clear it trusts its development at the position. What else did we learn in January?
Missouri's offensive line was somewhat tumultuous last season. Despite having key returners like Cayden Green at left tackle and Connor Tollison at center, there were still multiple holes and shaky ...
Deion Sanders and Colorado went 3-9 in 2025. Raymond Carlin III / Imagn Images Not all pressure is created equally. Some transfer portal classes will find that out soon enough. Some will be stepping ...
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases ...